Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||a 7 amino acid peptide near the carboxy terminus of human OCC-1.|
|Purification||Antigen affinity chromatography|
|Contains||0.02% sodium azide|
|Storage Conditions||Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C|
|Tested Applications||Dilution *|
|Immunohistochemistry (IHC)||2.5 µg/ml|
|Western Blot (WB)||2-4 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Despite the predicted molecular weight, OCC-1 from cell lines often migrates at ~28kDa in SDS-PAGE. A suggested positive control is 293 cell lysate.
PA5-20672 can be used with blocking peptide PEP-0790.
OCC-1 (Overexpressed in colon carcinoma-1) was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC-1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC-1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC-1 mRNA species are known to exist.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
adipogenesis down-regulated 3; AGD3, OCC-1, OCC1; overexpressed in colon carcinoma 1 protein; overexpressed in colon carcinoma-1; putative overexpressed in colon carcinoma-1 protein variant C
AGD3; C12orf75; OCC-1; OCC1